Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ipsen
Biotech
Ipsen scores 2nd ADC via $1B biobucks pact with Foreseen
Ipsen is back with its second ADC deal of the year, this time signing a $1 billion pact with Foreseen for a preclinical solid tumor candidate.
James Waldron
Jul 11, 2024 8:14am
Ipsen, Marengo ink $1.2B biobuck deal to treat cold tumors
Jun 7, 2024 9:15am
BridgeBio, Ipsen, George Medicines and more—Chutes & Ladders
May 3, 2024 8:30am
Ipsen dives into $1.8B Skyhawk pact to fire up RNA modulator R&D
Apr 22, 2024 7:01am
Ipsen posts mixed liver disease data on Intercept, CymaBay rival
Nov 14, 2023 5:55am
Ipsen still out of luck as EC rejects rare disease drug
Jul 20, 2023 6:32am
